MX Labs develops Shen.AI, an AI-powered monitoring system that uses remote photoplethysmography (rPPG) and computer vision to measure heart performance, blood pressure, and other vital indicators. The technology aims to enable early detection and monitoring of lifestyle-related disorders such as hypertension. The startup primarily serves telemedicine clients across more than 20 countries. Founders Remigiusz Kościelny and Przemysław Jaworski lead the company’s product and technical efforts. The company plans to use new capital to advance Shen.AI and expand its market presence. The financing details reported did not disclose the amount. MX Labs develops Shen.AI, a computer-vision and deep-learning diagnostic engine that uses a smartphone or computer camera to measure heart rate, heart rate variability and blood pressure from a one-minute facial scan. The technology is currently embedded in Heart Monitor, a mobile app available on the Apple App Store and Google Play (coming soon on CheckBP.com), which has been downloaded by over 80,000 people. With new funding, the company plans to expand Shen.AI's cardiovascular and mental-health capabilities and add functionality such as emotional-state detection and behavioral markers. MX Labs says it will invest in high-quality data acquisition, external collaborations with scientific institutions, and medical certification to position the product for telemedicine use. The founders have stated a goal of offering a medically certified diagnostic solution accessible through consumer devices and to deliver the expanded features to first customers later this year. The company is based in Estonia and frames its product as an affordable remote monitoring tool for prevention, self-care and telemedicine augmentation. MX Labs develops Shen.AI, a computer-vision and vital-signs platform that powers two smartphone apps—Heart Monitor and Beauty—to deliver contactless measurements of pulse, blood pressure, HRV, breathing rate, skin and eye assessments using only a camera. The apps are designed to be free to download with premium subscription features; the company says it will offer premium tiers though pricing details were not disclosed. MX Labs is pursuing AAMI-level blood-pressure accuracy, plans clinical trials, and aims for SaMD and CE certification once accuracy targets are met. The company provides an SDK for integration with mobile, desktop and embedded hardware and plans to add sensor and external data streams (e.g., Google Fit, Apple Health) for improved accuracy and telemedicine use cases. MX Labs is working with medical institutions including Antoni Jurasz University Hospital No. 1 in Bydgoszcz and partners in Africa and Southeast Asia to collect several thousand labeled recordings for model training; research participants are offered a free three-month app subscription. The team numbered eight at the time of reporting and the startup plans to grow to about 14 employees by year end.

Total raised

$3M

Funding rounds

3

Latest round

Seed

Latest activity

Feb 2022